Admission Date: [**2178-3-16**]        Discharge Date: [**2178-3-20**]  Date of Birth:  [**2110-6-6**]        Sex:  M  Service:  OME   HISTORY OF PRESENT ILLNESS:  Mr. [**Known lastname 68742**] is a 67-year-old male with metastatic renal cell carcinoma, admitted to begin cycle 1, week 2 high-dose IL-2 on the select IL-2 protocol.
His oncologic history began in the winter of [**2175**], when he developed a right varicocele and hematuria with CT confirming a right renal mass.
Serial scans confirmed growth and he began cycle 1, week 1 high-dose IL-2 on the select IL-2 trial on [**2178-2-24**], receiving 7 of 14 doses, with course complicated by dyspnea, hypoxia and neurotoxicity.
His echocardiogram today reveals a small pericardial effusion without tamponade, which appears loculated.
Left ventricular EF is greater than 65%.
Chest x- ray reveals a small left pleural effusion with worsening left lower lobe opacity.
VITAL SIGNS:  97.6, 83, 20, 134/74, O2 saturation 95% in room air.
CHEST:  Dull to percussion at the left base with absent breath sounds at the left base.
Clear to auscultation on the right.
ADMISSION LABS:  WBC 10.8, hemoglobin 13.2, hematocrit 40, platelet count 732,000, BUN 16, creatinine 1.2, sodium 136, potassium 4.9, chloride 102, CO2 29, glucose 119, CK 41, ALT 57, AST 32, albumin 2.9, INR 1.2, calcium 8.4, phosphorus 3.5, magnesium 2.3, total bilirubin 0.6.
His admission weight was 120 kg.
Blood cultures were sent to rule out infection, and he was maintained on vancomycin and cefepime.
He transferred back to the floor 2 days later, one weaned from blood pressure support.
One set of blood cultures drawn from arterial line on [**2178-3-18**] revealed 1 of 2 bottles positive for staph coag negative, felt to be a contaminant.
He had followup blood cultures x2 sets on [**2178-3-19**], without evidence of growth.
His antibiotics were continued until his blood cultures returned.
FOLLOWUP PLANS:  Mr. [**Known lastname 68742**] will return to clinic in 4 weeks after CT scans to assess disease response.
